Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
India Plans Rapid COVID-19 Vaccine Supply Expansion and Sputnik Introduction

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Politics

India Plans Rapid COVID-19 Vaccine Supply Expansion and Sputnik Introduction

Analysed 11 Nov 2026·2 sources analysed·India·Politics
India Plans Rapid COVID-19 Vaccine Supply Expansion and Sputnik IntroductionPreviousNext

Officials from NITI Aayog and Dr. Reddy's Laboratories discussed India's COVID-19 vaccination efforts, highlighting plans to expand vaccine supply. Rajiv Kumar noted increased domestic production capacity and imports, aiming for rapid vaccination of all adults. GV Prasad emphasized the complexity of scaling vaccine manufacturing, expecting Sputnik vaccine availability soon and supporting price cap removal to encourage investment while maintaining social support for vulnerable groups.

Sentiment
65%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (65/100). Lens Score 56/100.

Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 11 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (65/100)

Sentiment was consistent across outlets (55–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

economictimes broke this story on 11 Nov, 09:13 am. Other outlets followed.

11 Nov, 09:13 am2 sources · 0 min11 Nov, 09:13 am
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byPrajakta Kale· Political Analyst· editorial standards byOjas Kale
← Previous
Tejashwi Yadav Alleges Mafia Influence and Governance Issues in Bihar Under NDA
Next →
Sam Pitroda Denies Foreign Funding Claims Amid BJP's George Soros Allegations
economictimes11 Nov, 09:13 am
India to soon see very quick ramping up of vaccine supply: Rajiv Kumar, NITI Aayog
  • 2
    economictimes11 Nov, 09:13 am
    DRL's GV Prasad on vaccine ramp-up, Sputnik plan and price cap removal
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    National Health AuthorityGovernment of IndiaNITI Aayog
    Corporate
    Serum InstituteBharat BiotechDr. Reddy's Laboratories

    Story context

    Category
    Politics
    Location
    India
    Sources analysed
    2
    Last analysed
    11 Nov 2026
    Key entities
    VaccineSputnik 1IndiaSerum Institute of IndiaBharat BiotechRajiv Kumar (economist)NITI AayogVaccinationNational Health AuthorityRam Sewak SharmaStrike actionSputnik V COVID-19 vaccine